Coloplast A/S/€COLOB
06:30
16:10
01:45
11:25
21:00
1D1W1MYTD1Y5YMAX
About Coloplast A/S
Coloplast A/S is a Danish multinational company that specializes in the development and manufacture of medical devices and services. The company's core business operates within the healthcare sector, offering products and services that focus on ostomy care, urology, continence care, and wound and skin care. Founded in 1957 and headquartered in Humlebæk, Denmark, Coloplast has established a strong presence in numerous countries, serving healthcare professionals and patients around the globe. Its strategic positioning is supported by a commitment to innovation and close collaboration with healthcare professionals to ensure the efficacy and safety of its offerings. Coloplast's competitive strengths derive from its comprehensive product portfolio and strong expertise in chronic care solutions.
Ticker
€COLOB
Sector
Primary listing
XGAT
Employees
16,744
Headquarters
Humlebæk, Denmark
Website
Coloplast A/S Metrics
BasicAdvanced
€16B
33.49
€2.16
0.62
€3.08
4.26%
Price and volume
Market cap
€16B
Beta
0.62
52-week high
€114.04
52-week low
€71.52
Average daily volume
12K
Dividend rate
€3.08
Financial strength
Current ratio
1.607
Quick ratio
0.941
Long term debt to equity
124.358
Total debt to equity
140.423
Dividend payout ratio (TTM)
136.36%
Interest coverage (TTM)
10.25%
Profitability
EBITDA (TTM)
1,155.643
Gross margin (TTM)
67.97%
Net profit margin (TTM)
13.04%
Operating margin (TTM)
27.70%
Effective tax rate (TTM)
40.95%
Revenue per employee (TTM)
€222,290
Management effectiveness
Return on assets (TTM)
10.01%
Return on equity (TTM)
21.35%
Valuation
Price to earnings (TTM)
33.487
Price to revenue (TTM)
4.368
Price to book
7.57
Price to tangible book (TTM)
-8.99
Price to free cash flow (TTM)
23.332
Free cash flow yield (TTM)
4.29%
Free cash flow per share (TTM)
3.1
Dividend yield (TTM)
4.26%
Growth
Revenue change (TTM)
3.12%
Earnings per share change (TTM)
-28.18%
3-year revenue growth (CAGR)
7.27%
10-year revenue growth (CAGR)
7.20%
3-year earnings per share growth (CAGR)
-9.98%
10-year earnings per share growth (CAGR)
14.40%
3-year dividend per share growth (CAGR)
4.77%
10-year dividend per share growth (CAGR)
11.14%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Coloplast A/S stock?
Coloplast A/S (COLOB) has a market cap of €16B as of January 26, 2026.
What is the P/E ratio for Coloplast A/S stock?
The price to earnings (P/E) ratio for Coloplast A/S (COLOB) stock is 33.49 as of January 26, 2026.
Does Coloplast A/S stock pay dividends?
Yes, the Coloplast A/S (COLOB) stock pays dividends to shareholders. As of January 26, 2026, the dividend rate is €3.0802 and the yield is 4.26%. Coloplast A/S has a payout ratio of 136.36% on a trailing twelve-month basis.
When is the next Coloplast A/S dividend payment date?
The next Coloplast A/S (COLOB) dividend payment date is unconfirmed.
What is the beta indicator for Coloplast A/S?
Coloplast A/S (COLOB) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.